Pravastatin for early‐onset pre‐eclampsia: a randomised, blinded, placebo‐controlled trial

Abstract

Pravastatin does not improve maternal plasma sFlt-1 or placental growth factor levels following a diagnosis of early preterm pre-eclampsia #clinicaltrial finds.